Developer docs
API playgroundTry for free, no card

Search company profiles

SynBiotic

Full company profile

uuid00026or

Namestring
SynBiotic
Legal namestring
SYNBIOTIC SE
Websiteurl
synbiotic.com
Company typeenum
Public
Founded yearint
2020
Descriptiontext

SynBiotic SE is a publicly listed European holding company (Frankfurt: SBX) headquartered in Düsseldorf, Germany, that positions itself as Europe's largest vertically integrated hemp and cannabis group. It operates across three business segments: medical cannabis (60% of revenue, encompassing WEECO Pharma, SynBiotic Distribution, MH medical hemp, GOC Nexus, and Greensby), industrial hemp (40% of revenue, including HANF FARM's 1,000 ha of cultivation, Hemp Factory's raw materials processing, Hempro International's wholesale, and Ilesol's CBD extraction in Croatia), and recreational cannabis (Bushdoctor in Austria). The group sells B2B to pharmacies, pharmaceutical wholesalers, and food manufacturers, and B2C through brands such as Hempamed, BioCBD, AlterLife, and Canobo. Revenue mechanics are transaction-based across all segments with no disclosed subscription or platform fees.

The group's technology stack centers on pharmaceutical-grade cannabis processing: GOC Nexus is commercializing a patent-pending cold plasma decontamination method that received BfArM GMP certification in February 2026, and Ilesol operates a 3,400m² EU-certified extraction facility. SynBiotic pursues a buy-and-build platform strategy, having completed multiple acquisitions between 2020 and 2024 (including Ilesol for EUR 2.6M in April 2024 and WEECO Pharma in November 2024) and is led by founder-CEO Daniel Kruse, a hemp industry pioneer active since 1995. Following an October 2025 profit warning that cut revenue guidance by nearly 50%, the company is undergoing a significant portfolio cleanup: Hempro International, HANF FARM, Hemp Factory, and Bushdoctor are moving toward insolvency or liquidation, with EUR 13-14M in expected FY2025 exceptional write-downs, while a CANSOUL-led strategic investment (December 2025) and the medical cannabis pivot via GOC Nexus anchor the post-restructuring business case.

Short descriptiontext

SynBiotic SE is a publicly listed German holding company operating Europe's largest vertically integrated hemp and cannabis group, importing and distributing medical cannabis to pharmacies, selling industrial hemp raw materials to food manufacturers, and marketing CBD consumer brands across Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDüsseldorf, Germany
HQ citystring
Düsseldorf
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis distribution, industrial hemp processing, cannabis cultivation wholesale, CBD consumer products, hemp food ingredients
Industry2 codes
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYAFAIAJAK
Organic & Natural Foods Import/Export & Global Trading
NAICS code3 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
SIC code3 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Cannabis and Hemp Products
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Cannabis
TypeTransaction Fee
Description

60% of revenue from cultivation, import, R&D/Production, and sales & distribution of medical cannabis products including cannabis genetics, pharmaceutical products, and medical devices. Import partnerships in Netherlands, Denmark, Spain, Portugal, Thailand and Canada.

synbiotic.com
2Industrial Hemp
TypeTransaction Fee
Description

40% of revenue from hemp cultivation (1000 ha), production and distribution of hemp food raw materials including hemp seeds, hemp oil, hemp flour, hemp protein powder, hemp fiber, and hemp-based consumer products. B2B sales to food manufacturers, bakeries, and wholesalers plus B2C retail.

synbiotic.com
3Recreational Cannabis
TypeTransaction Fee
Description

Revenue from home cultivation products and accessories including seeds, cuttings, growing supplies. Bushdoctor offers up to 4,000 products in range.

synbiotic.com
4CBD Consumer Products
TypeTransaction Fee
Description

Sale of CBD products including oils, cosmetics, and dietary supplements through Solidmind Group brands (Hempamed, BioCBD) and Ilesol production.

synbiotic.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1Hanf Farm
Description

Hemp cultivation and production brand, 1000 ha cultivation area in Germany

synbiotic.com
+8 more records
Core offering1 text field

SynBiotic SE is a publicly listed European holding company operating across the medical cannabis and industrial hemp value chain. Through its 10+ subsidiaries, it imports, processes, distributes, and retails medical cannabis to pharmacies and clinical facilities in Germany, cultivates industrial hemp on 1,000 hectares, produces hemp food raw materials and CBD extracts, and sells CBD consumer products via own brands (Hempamed, BioCBD, Canobo) and home-grow supplies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 22% of FY2024 revenue from three subsidiaries before restructuring
+2 more records
Product overview1 text field

SYNBIOTIC SE is a publicly listed European holding company (ISIN: DE000A3E5A59) operating in medical cannabis and industrial hemp sectors, integrating the entire value chain from seed to shelf. The portfolio operates across three business segments: Medical Cannabis (WEECO Pharma, MH medical hemp, SynBiotic Distribution, GOC Nexus, Greensby), Industrial Hemp (HANF FARM, Hemp Factory, Hempro International, Ilesol, Lean Labs, CannaCare, WellNetIQ), and Recreational Cannabis (Bushdoctor). Revenue is distributed 60% medical cannabis and 40% industrial hemp. The group offers CBD consumer products through brands including Hempamed, BioCBD, and AlterLife under the Solidmind Group umbrella, while operating B2B operations in cultivation, extraction, processing, wholesale, and distribution of hemp and cannabis products.

Product and service13 records
1WEECO Pharma Medical Cannabis Wholesale
CategoryMedical Cannabis Distribution
Description

German importer and wholesaler bringing together an international network of medical cannabis producers, specializing in national and international trade in medicinal cannabis including genetics and increasing focus on magistral formulations. Serves pharmacies and pharmaceutical wholesalers.

2MH medical hemp CBD Extracts
CategoryCBD Extraction and Manufacturing
Description

Specializes in extraction of CBD, production and marketing of hemp-based cannabinoids and CBD-containing products, offering bulk CBD extracts, CBD oils and CBD isolates for manufacturers worldwide; in GMP certification process for pharmaceutical production of cannabinoid-based medicines.

3SynBiotic Distribution Medical Cannabis Supply
CategoryMedical Cannabis Distribution
Description

Import and distribution of high-quality medical cannabis products, supplying pharmacies, pharmaceutical wholesalers and clinical facilities throughout Germany with cannabinoid-containing medicines and medical devices since 2017.

4HANF FARM Hemp Cultivation and Production
CategoryIndustrial Hemp Cultivation
Description

Specializes in cultivation, processing and global marketing of premium hemp products since 1996, with 1,000 hectares of cultivation area in Germany and 10,000m² production area.

5Hemp Factory Hemp Food Raw Materials
CategoryHemp Food Processing
Description

Producer of hemp food raw materials in organic and conventional quality providing germ reduction, cleaning, hulling and roasting of hemp seeds, production of hemp oil, flour, protein powder and fiber. B2B sales to food manufacturers, bakeries, and wholesalers.

6Hempro International Wholesale and Retail
CategoryCannabis Wholesale and Retail
Description

Leading supplier in wholesale and retail specializing in raw materials and consumer products in the cannabis sector with over 26 years of experience supplying renowned wholesalers and food processing industry worldwide.

7Ilesol CBD Extracts and Isolates
CategoryCBD Extraction and Manufacturing
Description

Industrial manufacturer of cannabinoid extracts and CBD isolates with 3,400m² EU-certified production facility in Croatia, producing natural CBD cosmetics and dietary supplements.

8Hempamed CBD Consumer Brand
CategoryCBD Consumer Products
Description

Premium CBD product brand under Solidmind Group offering CBD oils, capsules, sleep drops, and specialized wellness formulations sold via Hempamed.de e-commerce.

9Bushdoctor Hemp Retail and Grow Supplies
CategoryHemp Retail and Grow Supplies
Description

Established hemp business in Austria with over 25 years of experience and six branches offering up to 4,000 items in seeds, cuttings, growing supplies and hemp products for home cultivation.

10Greensby Medical Cannabis Digital Platform
CategoryMedical Cannabis Digital Platform
Description

Digital platform connecting patients, pharmacies and prescribers, providing detailed terpene and cannabinoid profiles and batch-specific data for transparent, evidence-based strain selection.

11BioCBD Organic CBD Oils
CategoryCBD Consumer Products
Description

Organic CBD product line under Solidmind Group focused on premium quality CBD oils and wellness products sold via biocbd.de.

12Canobo CBD Wellness Brand
CategoryCBD Consumer Products
Description

German manufacturer and wholesaler of CBD products under the Canobo brand, focused on transferring traditional properties of hemp plant into modern formulations with emphasis on transparency and quality.

13WellNetIQ Cannabinoid Wellness Products
CategoryCBD Wellness Products
Description

Direct sale of cannabinoid-containing wellness products with focus on human relationships, ethical values and transparency.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

SYNBIOTIC holds 15.1% stake in GOC Nexus, a canna-tech company focused on cannabis processing with patent-pending cold plasma technology. GOC received GMP certification from BfArM in February 2026, enabling operational activities in import and processing of medical cannabis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-04-19
Description

SYNBIOTIC SE entered agreement to acquire all shares of Ilesol Pharmaceuticals d.o.o. in Croatia for EUR 2.6 million. Ilesol is an industrial manufacturer of cannabinoid extracts and CBD isolates with 3,400 m² EU-certified production facility. Transaction focuses on strengthening CBD extraction capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint venture between SYNBIOTIC SE and Enchilada Group to launch the first cannabis store in Germany. This partnership combines retail expertise with cannabis product supply to serve the emerging recreational cannabis market as German legalization progresses.

4International Cannabis Import Partners
Strategic tierCoreTypeOthers
Description

WEECO Pharma maintains import partnerships with medical cannabis producers from Netherlands, Denmark, Spain, Portugal, Thailand and Canada. These international partnerships provide supply chain access for EU GMP medical cannabis products.

synbiotic.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the world's largest cannabis companies founded by SynBiotic advisory board member Bruce Linton. Comparable as a vertically integrated cannabis platform pursuing medical and consumer segments across multiple geographies.

TypeDirect peer
Description

Vertically integrated cannabis and greenhouse produce operator with international medical cannabis exposure. Comparable to SynBiotic on the controlled-environment cultivation and processing side, particularly via HANF FARM.

TypeDirect peer
Description

Germany-based medical cannabis cultivator and distributor with BfArM licensing. Direct domestic peer to SynBiotic Distribution and WEECO Pharma operating in the same German pharmacy-channel medical cannabis value chain.

TypeDirect peer
Description

Canadian licensed cannabis producer with international medical cannabis export focus. Comparable as a peer-sized cannabis operator pursuing EU-GMP certified medical cannabis distribution.

TypeDirect peer
Description

Australian-headquartered cannabis cultivator and manufacturer with EU-GMP operations. Comparable to SynBiotic as a peer-sized medical cannabis supplier pursuing EU pharmacy-channel distribution.

TypeDirect peer
Description

Canadian licensed producer of medical and recreational cannabis with German and European distribution presence. Comparable to SynBiotic as a multi-jurisdiction cannabis operator navigating medical cannabis import and pharmacy distribution channels in Europe.

TypeBroad incumbent
Description

Canadian cannabis operator with international medical cannabis ambitions. Comparable as a publicly listed cannabis platform pursuing geographic and product diversification across multiple regulated markets.

TypeDirect peer
Description

German medical cannabis wholesaler and importer working with international producers. Direct domestic peer to WEECO Pharma and SynBiotic Distribution in the German pharmacy medical cannabis supply chain.

9Flora Growth
TypeEmerging player
Description

International cannabis and hemp CPG operator with European distribution. Comparable to SynBiotic as a multi-jurisdiction cannabis/hemp platform pursuing both medical cannabis and consumer hemp product revenues.

10Tilray Brands
TypeBroad incumbent
Description

Global cannabis and CPG company with significant European medical cannabis footprint through Tilray Medical. Comparable to SynBiotic in distributing medical cannabis to pharmacies across Germany and the EU.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries14 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SynBiotic

Cannabis and Hemp Productssynbiotic.com

SynBiotic SE is a publicly listed German holding company operating Europe's largest vertically integrated hemp and cannabis group, importing and distributing medical cannabis to pharmacies, selling industrial hemp raw materials to food manufacturers, and marketing CBD consumer brands across Europe.

What SynBiotic does

SynBiotic SE is a publicly listed European holding company (Frankfurt: SBX) headquartered in Düsseldorf, Germany, that positions itself as Europe's largest vertically integrated hemp and cannabis group. It operates across three business segments: medical cannabis (60% of revenue, encompassing WEECO Pharma, SynBiotic Distribution, MH medical hemp, GOC Nexus, and Greensby), industrial hemp (40% of revenue, including HANF FARM's 1,000 ha of cultivation, Hemp Factory's raw materials processing, Hempro International's wholesale, and Ilesol's CBD extraction in Croatia), and recreational cannabis (Bushdoctor in Austria). The group sells B2B to pharmacies, pharmaceutical wholesalers, and food manufacturers, and B2C through brands such as Hempamed, BioCBD, AlterLife, and Canobo. Revenue mechanics are transaction-based across all segments with no disclosed subscription or platform fees.

The group's technology stack centers on pharmaceutical-grade cannabis processing: GOC Nexus is commercializing a patent-pending cold plasma decontamination method that received BfArM GMP certification in February 2026, and Ilesol operates a 3,400m² EU-certified extraction facility. SynBiotic pursues a buy-and-build platform strategy, having completed multiple acquisitions between 2020 and 2024 (including Ilesol for EUR 2.6M in April 2024 and WEECO Pharma in November 2024) and is led by founder-CEO Daniel Kruse, a hemp industry pioneer active since 1995. Following an October 2025 profit warning that cut revenue guidance by nearly 50%, the company is undergoing a significant portfolio cleanup: Hempro International, HANF FARM, Hemp Factory, and Bushdoctor are moving toward insolvency or liquidation, with EUR 13-14M in expected FY2025 exceptional write-downs, while a CANSOUL-led strategic investment (December 2025) and the medical cannabis pivot via GOC Nexus anchor the post-restructuring business case.

SynBiotic firmographics

Firmographics
Name
SynBiotic
Legal name
SYNBIOTIC SE
Website
https://synbiotic.com
Company type
Public
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
SynBiotic SE is a publicly listed German holding company operating Europe's largest vertically integrated hemp and cannabis group, importing and distributing medical cannabis to pharmacies, selling industrial hemp raw materials to food manufacturers, and marketing CBD consumer brands across Europe.
Ownership category
akta.pro rank

SynBiotic industry classification

Industry
Product category
Cannabis and Hemp Products
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYAFAIAJAK
Organic & Natural Foods Import/Export & Global Trading

Keywords

  • Medical cannabis distribution
  • Industrial hemp processing
  • Cannabis cultivation wholesale
  • CBD consumer products
  • Hemp food ingredients

Where SynBiotic is headquartered

Location

Headquarters

HQ city
Düsseldorf
HQ country
Germany
HQ region
Europe

Offices10 records

Markets served

SynBiotic business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Cannabis: 60% of revenue from cultivation, import, R&D/Production, and sales & distribution of medical cannabis products including cannabis genetics, pharmaceutical products, and medical devices. Import partnerships in Netherlands, Denmark, Spain, Portugal, Thailand and Canada.
  2. Industrial Hemp: 40% of revenue from hemp cultivation (1000 ha), production and distribution of hemp food raw materials including hemp seeds, hemp oil, hemp flour, hemp protein powder, hemp fiber, and hemp-based consumer products. B2B sales to food manufacturers, bakeries, and wholesalers plus B2C retail.
  3. Recreational Cannabis: Revenue from home cultivation products and accessories including seeds, cuttings, growing supplies. Bushdoctor offers up to 4,000 products in range.
  4. CBD Consumer Products: Sale of CBD products including oils, cosmetics, and dietary supplements through Solidmind Group brands (Hempamed, BioCBD) and Ilesol production.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels5 records

SynBiotic product offering

Product offering

Core offering

SynBiotic SE is a publicly listed European holding company operating across the medical cannabis and industrial hemp value chain. Through its 10+ subsidiaries, it imports, processes, distributes, and retails medical cannabis to pharmacies and clinical facilities in Germany, cultivates industrial hemp on 1,000 hectares, produces hemp food raw materials and CBD extracts, and sells CBD consumer products via own brands (Hempamed, BioCBD, Canobo) and home-grow supplies.

Product overview

SYNBIOTIC SE is a publicly listed European holding company (ISIN: DE000A3E5A59) operating in medical cannabis and industrial hemp sectors, integrating the entire value chain from seed to shelf. The portfolio operates across three business segments: Medical Cannabis (WEECO Pharma, MH medical hemp, SynBiotic Distribution, GOC Nexus, Greensby), Industrial Hemp (HANF FARM, Hemp Factory, Hempro International, Ilesol, Lean Labs, CannaCare, WellNetIQ), and Recreational Cannabis (Bushdoctor). Revenue is distributed 60% medical cannabis and 40% industrial hemp. The group offers CBD consumer products through brands including Hempamed, BioCBD, and AlterLife under the Solidmind Group umbrella, while operating B2B operations in cultivation, extraction, processing, wholesale, and distribution of hemp and cannabis products.

Differentiator

Problem solved

Functional benefit

Brands

  • Hanf Farm: Hemp cultivation and production brand, 1000 ha cultivation area in Germany
  • Hempamed
  • BioCBD
  • AlterLife
  • The Hemp Line
  • PURE
  • Canobo
  • Phytalize
  • Plantoplus

Products and services

  • WEECO Pharma Medical Cannabis Wholesale German importer and wholesaler bringing together an international network of medical cannabis producers, specializing in national and international trade in medicinal cannabis including genetics and increasing focus on magistral formulations. Serves pharmacies and pharmaceutical wholesalers.
  • MH medical hemp CBD Extracts Specializes in extraction of CBD, production and marketing of hemp-based cannabinoids and CBD-containing products, offering bulk CBD extracts, CBD oils and CBD isolates for manufacturers worldwide; in GMP certification process for pharmaceutical production of cannabinoid-based medicines.
  • SynBiotic Distribution Medical Cannabis Supply Import and distribution of high-quality medical cannabis products, supplying pharmacies, pharmaceutical wholesalers and clinical facilities throughout Germany with cannabinoid-containing medicines and medical devices since 2017.
  • HANF FARM Hemp Cultivation and Production Specializes in cultivation, processing and global marketing of premium hemp products since 1996, with 1,000 hectares of cultivation area in Germany and 10,000m² production area.
  • Hemp Factory Hemp Food Raw Materials Producer of hemp food raw materials in organic and conventional quality providing germ reduction, cleaning, hulling and roasting of hemp seeds, production of hemp oil, flour, protein powder and fiber. B2B sales to food manufacturers, bakeries, and wholesalers.
  • Hempro International Wholesale and Retail Leading supplier in wholesale and retail specializing in raw materials and consumer products in the cannabis sector with over 26 years of experience supplying renowned wholesalers and food processing industry worldwide.
  • Ilesol CBD Extracts and Isolates Industrial manufacturer of cannabinoid extracts and CBD isolates with 3,400m² EU-certified production facility in Croatia, producing natural CBD cosmetics and dietary supplements.
  • Hempamed CBD Consumer Brand Premium CBD product brand under Solidmind Group offering CBD oils, capsules, sleep drops, and specialized wellness formulations sold via Hempamed.de e-commerce.
  • Bushdoctor Hemp Retail and Grow Supplies Established hemp business in Austria with over 25 years of experience and six branches offering up to 4,000 items in seeds, cuttings, growing supplies and hemp products for home cultivation.
  • Greensby Medical Cannabis Digital Platform Digital platform connecting patients, pharmacies and prescribers, providing detailed terpene and cannabinoid profiles and batch-specific data for transparent, evidence-based strain selection.
  • BioCBD Organic CBD Oils Organic CBD product line under Solidmind Group focused on premium quality CBD oils and wellness products sold via biocbd.de.
  • Canobo CBD Wellness Brand German manufacturer and wholesaler of CBD products under the Canobo brand, focused on transferring traditional properties of hemp plant into modern formulations with emphasis on transparency and quality.
  • WellNetIQ Cannabinoid Wellness Products Direct sale of cannabinoid-containing wellness products with focus on human relationships, ethical values and transparency.

Quantifiable outcome

  • 22% of FY2024 revenue from three subsidiaries before restructuring
  • +2 more outcomes

Companies that use SynBiotic

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

SynBiotic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

SynBiotic partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor and core.

  • GOC NEXUS OPERATIONS GmbHminorStrategic or Co-development Partner · 1 February 2026SYNBIOTIC holds 15.1% stake in GOC Nexus, a canna-tech company focused on cannabis processing with patent-pending cold plasma technology. GOC received GMP certification from BfArM in February 2026, enabling operational activities in import and processing of medical cannabis.
  • Ilesol Pharmaceuticals d.o.o.coreStrategic or Co-development Partner · 19 April 2024SYNBIOTIC SE entered agreement to acquire all shares of Ilesol Pharmaceuticals d.o.o. in Croatia for EUR 2.6 million. Ilesol is an industrial manufacturer of cannabinoid extracts and CBD isolates with 3,400 m² EU-certified production facility. Transaction focuses on strengthening CBD extraction capabilities.
  • Enchilada GroupcoreStrategic or Co-development PartnerJoint venture between SYNBIOTIC SE and Enchilada Group to launch the first cannabis store in Germany. This partnership combines retail expertise with cannabis product supply to serve the emerging recreational cannabis market as German legalization progresses.
  • International Cannabis Import PartnerscoreOthersWEECO Pharma maintains import partnerships with medical cannabis producers from Netherlands, Denmark, Spain, Portugal, Thailand and Canada. These international partnerships provide supply chain access for EU GMP medical cannabis products.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

SynBiotic competitors and assessment

Company assessment

Broad incumbents

  • Canopy Growth Corporation: One of the world's largest cannabis companies founded by SynBiotic advisory board member Bruce Linton. Comparable as a vertically integrated cannabis platform pursuing medical and consumer segments across multiple geographies.
  • Cronos Group: Canadian cannabis operator with international medical cannabis ambitions. Comparable as a publicly listed cannabis platform pursuing geographic and product diversification across multiple regulated markets.
  • Tilray Brands: Global cannabis and CPG company with significant European medical cannabis footprint through Tilray Medical. Comparable to SynBiotic in distributing medical cannabis to pharmacies across Germany and the EU.

Direct peers

  • Village Farms International: Vertically integrated cannabis and greenhouse produce operator with international medical cannabis exposure. Comparable to SynBiotic on the controlled-environment cultivation and processing side, particularly via HANF FARM.
  • Demecan: Germany-based medical cannabis cultivator and distributor with BfArM licensing. Direct domestic peer to SynBiotic Distribution and WEECO Pharma operating in the same German pharmacy-channel medical cannabis value chain.
  • OrganiGram Holdings: Canadian licensed cannabis producer with international medical cannabis export focus. Comparable as a peer-sized cannabis operator pursuing EU-GMP certified medical cannabis distribution.
  • Cannim: Australian-headquartered cannabis cultivator and manufacturer with EU-GMP operations. Comparable to SynBiotic as a peer-sized medical cannabis supplier pursuing EU pharmacy-channel distribution.
  • Aurora Cannabis: Canadian licensed producer of medical and recreational cannabis with German and European distribution presence. Comparable to SynBiotic as a multi-jurisdiction cannabis operator navigating medical cannabis import and pharmacy distribution channels in Europe.
  • Nimbus Health: German medical cannabis wholesaler and importer working with international producers. Direct domestic peer to WEECO Pharma and SynBiotic Distribution in the German pharmacy medical cannabis supply chain.

Emerging players

  • Flora Growth: International cannabis and hemp CPG operator with European distribution. Comparable to SynBiotic as a multi-jurisdiction cannabis/hemp platform pursuing both medical cannabis and consumer hemp product revenues.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

SynBiotic social profiles

Digital presence

SynBiotic compliance and trust

Trust signal

Compliance3 records

SynBiotic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SynBiotic leadership team

Management profile

Number of profiles

Profiles11 records

SynBiotic subsidiaries and ownership

Company hierarchy

Subsidiaries14 records

SynBiotic funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SynBiotic M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SynBiotic

What does SynBiotic do?

SynBiotic SE is a publicly listed European holding company operating across the medical cannabis and industrial hemp value chain. Through its 10+ subsidiaries, it imports, processes, distributes, and retails medical cannabis to pharmacies and clinical facilities in Germany, cultivates industrial hemp on 1,000 hectares, produces hemp food raw materials and CBD extracts, and sells CBD consumer products via own brands (Hempamed, BioCBD, Canobo) and home-grow supplies.

Is SynBiotic a public or private company?

SynBiotic is a public company. It is classified as public and is currently operating.

When was SynBiotic founded?

SynBiotic was founded in 2020. It employs 1 to 10 people.

Where is SynBiotic based?

SynBiotic is headquartered in Düsseldorf, Germany, in the Europe region.

How does SynBiotic make money?

Four revenue lines are on record. Medical Cannabis are the primary driver. The others are industrial Hemp, recreational Cannabis and CBD Consumer Products.

Who are SynBiotic's main competitors?

Broad incumbents on record are Canopy Growth Corporation, Cronos Group and Tilray Brands. Direct peers are Village Farms International, Demecan, OrganiGram Holdings, Cannim, Aurora Cannabis and Nimbus Health. Flora Growth is listed as an emerging player.

Does SynBiotic have an API?

No public API is recorded for SynBiotic.

What industry is SynBiotic in?

SynBiotic's product category is Cannabis and Hemp Products. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of AFAIAJAK, Organic & Natural Foods Import/Export & Global Trading. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinanzNachrichten.deSynBiotic SE-Aktie mit-74% - Kurs implodiertSynBiotic SE filed for insolvency at the Münster court after failed financing efforts and lack of approval for new capital measures. The stock fell 75.44% to €0.21, leaving the company's financial outlook uncertain.FinanzNachrichten.deSynbiotic SE geht in die InsolvenzSynbiotic SE will file for insolvency proceedings at the Münster district court. The cannabis-sector company could not secure financing in time, citing ongoing difficult market conditions that severely strained its business and financial situation.FinanzNachrichten.deEQS-Adhoc: SYNBIOTIC SE: Antrag auf Eröffnung eines InsolvenzverfahrensSYNBIOTIC SE applied to the Münster court for insolvency proceedings, citing the cannabis sector's difficult market conditions and failed financing efforts. The company expects a provisional insolvency administrator to be appointed and business to continue, but the outcome and impact on shareholders remain uncertain.FinanzNachrichten.deSYNBIOTIC SE: Portfoliobereinigung setzt die Basis neu; Kursziel gesenkt, bleibt jedoch Spek. KAUFENSYNBIOTIC SE is restructuring its portfolio after three subsidiaries—Hempro International, HANF FARM, and Hemp Factory—are moving toward liquidation or insolvency due to sharply declining demand in the hemp food and feed market in 2026. The affected subsidiaries accounted for approximately 22% of fiscal year 2024 revenue but generated significant losses, and their exit is expected to reduce cash outflows and improve earnings quality over time. However, fiscal year 2025 is expected to incur exceptional write-downs of 13–14 million EUR, while the investment case shifts toward a focused medical cannabis platform comprising WEECO Pharma, MH medical hemp, and SOLIDMIND.FinanzNachrichten.deEQS-Adhoc: SYNBIOTIC SE: Hempro International GmbH beabsichtigt Antrag auf Eröffnung eines vorläufigen InsolvenzverfahrensSYNBIOTIC SE announced that its subsidiary Hempro International GmbH intends to file for preliminary insolvency proceedings at the Local Court of Münster (Amtsgericht Münster). The insolvency filing follows deteriorating economic conditions stemming from geopolitical events, which caused a significant decline in demand for hemp food and hemp feed products since March 2026 despite initially strong sales in 2025. SYNBIOTIC SE, which will no longer provide financial support to Hempro International GmbH as part of its restructuring efforts, is currently evaluating the impact on its financial position.Business of CannabisGreen Shoots: Spring 2026 Brings Integration, Recovery, and New Supply Chains to Global CannabisThe global cannabis sector is showing tentative signs of stabilization in Q2 2026 as established operators pivot toward growth markets and new supply chain models. Curaleaf International has completed its integration of Polish clinic Fitokan, rebranding it as Curaleaf Centrum Medyczne and reinforcing its dominant European footprint spanning nine countries, with international revenues reaching $172.5m in 2025. German operator Synbiotic SE is recovering from a severe October 2025 profit warning that slashed revenue guidance by nearly 50%, having stabilized through portfolio cleanup, discontinuation of loss-making Austrian subsidiary Bushdoctor, and a strategic investment from cannabis fund CANSOUL. Aurora Cannabis has reversed typical supply chain dynamics by outsourcing manufacturing to Australian pharmaceutical company Bioxyne's subsidiary Breathe Life Sciences, with BLS manufacturing products for Aurora across multiple international markets including over 5,000 sublingual oil products and 20,000 vape units.EIN PresswireSynbiotics Market Growth Accelerates to USD 3.36 Billion by 2032 Demand for Gut Microbiota & Digestive Health SolutionsThe Global Synbiotics Market is projected to grow from USD 1.90 billion in 2024 to USD 3.36 billion by 2032, registering a CAGR of 7.4% during 2025–2032, driven by rising demand for gut health supplements, functional foods, and nutraceutical innovations. Key recent developments include SynBiotic SE securing a €2.4 million strategic investment from IRIS Capital in April 2025 and Seed Health, Inc. launching its DS-01 Daily Synbiotic across Sprouts Farmers Market stores nationwide in June 2025. Market challenges include low shelf-life of probiotic formulations, high production costs, and limited consumer awareness in emerging Asia-Pacific regions.GlobeNewswireGermany Legal Cannabis Market Report 2025-2030: Competitive Analysis of The Cronos Group, Organigram, Tilray, Canopy Growth, Aurora Cannabis, SynBiotic, Cansativa, Four 20 Pharma, and Avextra PharmaThe German legal cannabis market was valued at USD 37.15 million in 2024 and is projected to reach USD 85.64 million by 2030, a CAGR of 14.09%. Hemp led the source segment with 84.50% share, and CBD led derivatives with 63.61%.CannabizeuSYNBIOTIC secures strategic investment from IRIS CapitalSYNBIOTIC announced a strategic alliance with IRIS Capital Investment, which will subscribe to convertible notes in tranches up to EUR 200,000 each, totaling EUR 2.4 million. The first tranche is set for release in April 2025, and the partnership aims to support SYNBIOTIC's expansion in Europe's legal cannabis sector.PharmiWeb.comIRIS Capital invests in SYNBIOTIC's growth strategyIRIS Capital Investment and SYNBIOTIC SE entered a strategic partnership, with IRIS committing up to EUR 2.4 million in non-interest-bearing convertible bonds. SYNBIOTIC's subsidiary WEECO Pharma exceeded its 2024 sales target, prompting upward adjustments to 2025-2027 sales plans.